News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,602 Results
Type
Article (24194)
Company Profile (149)
Press Release (462258)
Multimedia
Podcasts (86)
Webinars (16)
Section
Business (147309)
Career Advice (1534)
Deals (27358)
Drug Delivery (97)
Drug Development (58979)
Employer Resources (144)
FDA (11061)
Job Trends (11174)
News (250347)
Policy (23027)
Tag
Academia (1339)
Accelerated approval (4)
Adcomms (13)
Allergies (60)
Alliances (37496)
ALS (75)
Alzheimer's disease (944)
Antibody-drug conjugate (ADC) (108)
Approvals (11084)
Artificial intelligence (255)
Autoimmune disease (20)
Automation (13)
Bankruptcy (247)
Best Places to Work (8542)
BIOSECURE Act (18)
Biosimilars (80)
Biotechnology (79)
Bladder cancer (71)
Brain cancer (24)
Breast cancer (222)
Cancer (1917)
Cardiovascular disease (142)
Career advice (1297)
Career pathing (25)
CAR-T (136)
CDC (15)
Cell therapy (363)
Cervical cancer (16)
Clinical research (49577)
Collaboration (734)
Compensation (308)
Complete response letters (19)
COVID-19 (1463)
CRISPR (47)
C-suite (246)
Cystic fibrosis (79)
Data (2117)
Decentralized trials (1)
Denatured (36)
Depression (38)
Diabetes (196)
Diagnostics (4304)
Digital health (14)
Diversity (7)
Diversity, equity & inclusion (34)
Drug discovery (108)
Drug pricing (121)
Drug shortages (27)
Duchenne muscular dystrophy (86)
Earnings (57093)
Editorial (37)
Employer branding (17)
Employer resources (122)
Events (72147)
Executive appointments (721)
FDA (12239)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (619)
Gene editing (94)
Generative AI (22)
Gene therapy (268)
GLP-1 (545)
Government (2820)
Grass and pollen (4)
Guidances (160)
Healthcare (11204)
Huntington's disease (13)
IgA nephropathy (32)
Immunology and inflammation (84)
Immuno-oncology (2)
Indications (32)
Infectious disease (1562)
Inflammatory bowel disease (108)
Inflation Reduction Act (11)
Influenza (42)
Intellectual property (94)
Interviews (243)
IPO (12128)
IRA (49)
Job creations (2973)
Job search strategy (1119)
Kidney cancer (10)
Labor market (42)
Layoffs (279)
Leadership (19)
Legal (5139)
Liver cancer (54)
Lung cancer (268)
Lymphoma (146)
Machine learning (9)
Management (46)
Manufacturing (318)
MASH (74)
Medical device (8071)
Medtech (8075)
Mergers & acquisitions (15832)
Metabolic disorders (543)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (68)
Neuropsychiatric disorders (14)
Neuroscience (1402)
NextGen: Class of 2025 (4288)
Non-profit (1990)
Now hiring (21)
Obesity (284)
Opinion (241)
Ovarian cancer (76)
Pain (91)
Pancreatic cancer (81)
Parkinson's disease (124)
Partnered (18)
Patents (243)
Patient recruitment (98)
Peanut (25)
People (46616)
Pharmaceutical (70)
Pharmacy benefit managers (22)
Phase I (15075)
Phase II (21854)
Phase III (16849)
Pipeline (1293)
Policy (166)
Postmarket research (1707)
Preclinical (5983)
Press Release (59)
Prostate cancer (93)
Psychedelics (20)
Radiopharmaceuticals (212)
Rare diseases (334)
Real estate (4431)
Recruiting (60)
Regulatory (16766)
Reports (39)
Research institute (1352)
Resumes & cover letters (244)
Rett syndrome (9)
RNA editing (8)
RSV (22)
Schizophrenia (69)
Series A (113)
Series B (66)
Service/supplier (6)
Sickle cell disease (45)
Special edition (16)
Spinal muscular atrophy (100)
Sponsored (28)
Startups (2610)
State (2)
Stomach cancer (9)
Supply chain (62)
Tariffs (57)
The Weekly (48)
Vaccines (369)
Venture capitalists (34)
Weight loss (175)
Women's health (26)
Worklife (15)
Date
Last 7 days (368)
Last 30 days (1777)
Last 365 days (23874)
2025 (11320)
2024 (26339)
2023 (29981)
2022 (39077)
2021 (41191)
2020 (39391)
2019 (32672)
2018 (24566)
2017 (24092)
2016 (22473)
2015 (26412)
2014 (20098)
2013 (16752)
2012 (18249)
2011 (18987)
2010 (17067)
Location
Africa (567)
Alabama (35)
Alaska (5)
Arizona (131)
Arkansas (7)
Asia (32887)
Australia (6209)
California (4999)
Canada (1807)
China (526)
Colorado (227)
Connecticut (248)
Delaware (120)
Europe (65042)
Florida (794)
Georgia (132)
Idaho (33)
Illinois (471)
India (24)
Indiana (244)
Iowa (11)
Japan (178)
Kansas (87)
Kentucky (22)
Louisiana (10)
Maine (47)
Maryland (674)
Massachusetts (3793)
Michigan (175)
Minnesota (247)
Mississippi (3)
Missouri (62)
Montana (17)
Nebraska (20)
Nevada (70)
New Hampshire (59)
New Jersey (1608)
New Mexico (15)
New York (1533)
North Carolina (839)
North Dakota (8)
Northern California (2184)
Ohio (169)
Oklahoma (10)
Oregon (24)
Pennsylvania (1142)
Puerto Rico (14)
Rhode Island (24)
South America (897)
South Carolina (28)
Southern California (1921)
Tennessee (93)
Texas (751)
United States (19202)
Utah (134)
Virginia (150)
Washington D.C. (59)
Washington State (463)
West Virginia (4)
Wisconsin (48)
486,602 Results for "teva pharmaceutical industries limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
May 27, 2025
·
5 min read
Business
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
Teva Pharmaceutical Industries Ltd. today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024.
May 15, 2024
·
7 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Press Releases
Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
May 19, 2025
·
9 min read
Press Releases
Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day
May 29, 2025
·
11 min read
Pharm Country
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.
June 24, 2024
·
9 min read
Press Releases
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June 2025
May 28, 2025
·
2 min read
Policy
UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals
UroGen Pharma Ltd. today announced that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd., alleging infringement of U.S. Patent Numbers 9,040,074 (“the ’074 patent”) and 9,950,069.
April 3, 2024
·
9 min read
Press Releases
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
May 7, 2025
·
2 min read
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024.
June 4, 2024
·
2 min read
1 of 48,661
Next
